Navigation Links
Clinical trial will test new HIV/AIDS vaccine
Date:4/3/2008

BOSTON A phase 1 clinical trial to test a novel HIV/AIDS vaccine has begun at Brigham and Womens Hospital (BWH). This new vaccine aims to overcome the problem of preexisting immunity to common vaccine vectors, which is thought to be a major problem in the developing world.

This study will involve 48 healthy volunteers who will receive either two or three immunizations and who will be followed to assess the safety and immunogenicity of the vaccine, explains Lindsey R. Baden, MD, Assistant Professor of Medicine at BWH and Harvard Medical School and Protocol Chair for the study.

The vaccine consists of a replication-incompetent, recombinant adenovirus serotype 26 (rAd26) vector encoding an HIV-1 envelope gene.

The rAd26 vaccine vector was selected for its particularly low seroprevalence in human populations and for its potent immunogenicity and protective efficacy in preclinical studies, explains Dan H. Barouch, MD, PhD, Associate Professor of Medicine at Beth Israel Deaconess Medical Center (BIDMC) and Harvard Medical School and Principal Investigator of the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) program that developed the vaccine. This program is sponsored by the Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.

Manufactured by the Dutch biotechnology company Crucell Holland BV, the rAd26 vaccine is the first HIV-1 vaccine candidate to emerge from the IPCAVD initiative, which brings together investigators from academia and industry in an effort to accelerate the development of promising HIV/AIDS vaccine candidates. The novel strategy used in developing this vaccine enables researchers to circumvent preexisting immunity to the adenovirus serotype 5, the virus responsible for the common cold, which has recently shown limitations as an HIV-1 vaccine vector.

The rAd26 vector does not regularly occur in the human population and huma
'/>"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Radiologists encouraged to look beyond cancer for clinically unseen diseases
2. Clinical depression linked to abnormal emotional brain circuits
3. Preclinical study suggests organ-transplant drug may aid in lupus fight
4. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
5. Good Clinical Practice Journal Awards: Winners Announced
6. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
7. Study Questions Dead-End Cancer Clinical Trials
8. Genomic Health Announces Multiple Studies on Oncotype DX(TM) Presented at 2007 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium
9. Clinical trials present better alternatives for dialysis patients
10. Mirixa Debuts New Clinical Technology Solutions for Enhancing Patient Care
11. IMPACT initiative looks to improve patient participation in clinical trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... New Port Richey, FL (PRWEB) September 22, 2014 ... article, “medical marijuana dispensaries in [Berkeley] will be required ... to low-income residents” beginning in August, 2015. (1) ... Florida-based detox centers serving high-dosage drug abuse patients, ... only further contribute to the nation’s already rampant drug ...
(Date:9/22/2014)... Texas (PRWEB) September 22, 2014 ... and treatment, will work with companies to help employees ... the development of diabetes as part of a collaboration ... Diabetes @ Work initiative. , PreDiabetes Centers Medical ... Department of Transportation in Austin on Tuesday, October 21st ...
(Date:9/22/2014)... Health 2.0 8th Annual Fall Conference ... a leading provider of intelligent health information and ... to harness the power of structured and ... The new big data analytics platform leverages the ... language processing (NLP) technologies and semantic analysis to ...
(Date:9/22/2014)... HealthDay Reporter FRIDAY, Sept. ... people with type 2 diabetes found that intensively lowering ... attacks, strokes and deaths. But intensive blood sugar control ... the study, investigators followed nearly 8,500 participants of a ... pressure and blood sugar levels strictly controlled, while others ...
(Date:9/22/2014)... Caliper, an internationally recognized talent management consulting firm ... with the When Work Works Award for making work-life ... to increase business and employee success. , Caliper’s ... work and family commitments effectively. As a result, turnover ... high. , “At Caliper, our primary mission is ...
Breaking Medicine News(10 mins):Health News:New York Times Questions Gratuitous Medical Marijuana in California—Novus Medical Detox Says Increased Availability Encourages Overuse, Advises Against Movement 2Health News:New York Times Questions Gratuitous Medical Marijuana in California—Novus Medical Detox Says Increased Availability Encourages Overuse, Advises Against Movement 3Health News:New York Times Questions Gratuitous Medical Marijuana in California—Novus Medical Detox Says Increased Availability Encourages Overuse, Advises Against Movement 4Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 2Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 3Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 2Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 3Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 4Health News:Healthline’s New HealthData Engine Turns Unstructured Data Into Actionable Insights 5Health News:Tight Blood Sugar Control Doesn't Prevent Strokes in Diabetics: Study 2Health News:Tight Blood Sugar Control Doesn't Prevent Strokes in Diabetics: Study 3Health News:Caliper Recognized Second Year in a Row For Exemplary Workplace Practices 2Health News:Caliper Recognized Second Year in a Row For Exemplary Workplace Practices 3
... could lead to new treatments, researchers say , , WEDNESDAY, ... immune cells exhausted from fighting HIV infection has been ... that a molecule called Tim-3 is present at high ... combating HIV, the virus that causes AIDS. Blocking the ...
... physicians and caregivers to improve cultural sensitivity and ... these women to get mammograms that could save ... the Journal of General Internal Medicine. ... perceive they are being treated with disrespect and ...
... Latest Release Includes Enhanced Scheduling, Financial and ... Social Workers, GREAT RIVER, N.Y., Nov. ... of enterprise-wide software and services for health ... availability,release of version 7.5 of Helper, the ...
... bring enough benefit to offset expense , , WEDNESDAY, Nov. ... may not justify the marginal benefit, a new study ... (AHA) annual scientific sessions in New Orleans found that ... in some patients but "at a cost generally considered ...
... Demonstrate Best Strategic Use of Mergers ... ... http://www.thedeal.com ) magazine has named Abbott,( http://www.abbott.com )as the healthcare sector ... Abbott for the,most effective strategic use of acquisitions and divestitures., ...
... of Rutgers University is one of 10 2008 Pew ... Pew Charitable Trusts. Launched in 1991, the Pew Latin ... trained Latin American scientists who show potential for stimulating ... as well as fostering collaboration between scientists in Latin ...
Cached Medicine News:Health News:Way to Rescue Tired Immune Cells Fighting HIV Found 2Health News:Fear, misconceptions about screenings keep many African-Americans from getting mammograms 2Health News:Fear, misconceptions about screenings keep many African-Americans from getting mammograms 3Health News:Netsmart Technologies Releases Version 7.5 of Helper(TM) Practice Management Software 2Health News:Netsmart Technologies Releases Version 7.5 of Helper(TM) Practice Management Software 3Health News:Angioplasty Not Always Worth the Price 2Health News:Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers 2Health News:Abbott Honored as One of The Deal's Most Admired Corporate Dealmakers 3
(Date:9/22/2014)... 22, 2014 China Nepstar Chain Drugstore Ltd. (NYSE: ... chain in China based on the number ... 2014 Annual General Meeting of Shareholders (the "AGM") on October 22, ... at the meeting room of the Company at 6th Floor, Tower ... , Guangdong Province 518054, People,s ...
(Date:9/19/2014)... , Sept. 19, 2014 A pharmaceutical ... Practices, LLC with three issues he wanted the research ... use of external personnel (especially for secondary research) to ... the face of increased workload , Automation of ... knowledge management , How to implement and manage ...
(Date:9/19/2014)... , Sept. 19, 2014 /PRNewswire-iReach/ -- Market ... Hydrochloride Industry, 2009-2019 is a professional and ... Oxybutynin Hydrochloride industry. The report firstly reviews ... its classification, application and manufacturing technology. The ... manufacturers of Oxybutynin Hydrochloride listing their product ...
Breaking Medicine Technology:China Nepstar Chain Drugstore Schedules Annual General Meeting of Shareholders for October 22, 2014 2In Era of Competing Needs, Market Research Groups Under Pressure to Utilize Automation and External Staffing 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 2Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 3Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 4Oxybutynin Hydrochloride Industry 2014-2019 Chinese Forecasts & Analysis 5
... Feb. 18, 2011 Replacing both knees in one ... was associated with significantly fewer prosthetic joint infections as ... after surgery, compared with total knee replacements performed in ... a moderately higher risk of adverse cardiovascular outcomes within ...
... 18, 2011 Novavax, Inc. (Nasdaq: NVAX) ... final safety and immunogenicity results from its 2009 H1N1 ... Mexico at the invitation-only 7th World Health Organization Meeting ... Trials. The meeting was held at the WHO headquarters ...
Cached Medicine Technology:Two Knee Replacements May Be Better Than One 2NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 2NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 3NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 4NOVAVAX Presents Final Results from H1N1 Influenza Vaccine Trial at World Health Organization Meeting 5
... November 2005. Specifications, including colors, subject to ... lb (2.3 kg), FreeStyle by AirSep is ... for those patients who know no boundaries. ... FreeStyle captures the heart of what it ...
... is AirSep Corporations most economical line of ... lpm of therapeutic oxygen in home, hospital, ... of units in daily use throughout the ... known for high performance, easy maintenance, and ...
... to 10 LPM of oxygen reducing the delivery ... M10 is engineered to reduce the cost of ... fewer parts than any other concentrator on the ... you to reduce expenditure on accessories and unnecessary ...
... conserver, it's important to have a choice that ... name synonymous with innovative excellence, offers two great ... automatic and value packed conservers., ,With its ... used 8 hours a day for 3 to ...
Medicine Products: